Asthma Therapeutics Market 2028 By Product Type, Drug Class, Route of administration and Geography | The Insight Partners

report image

Asthma Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Dry powder inhalers, Metered dose inhalers, Mist inhalers, Nebulizer); Drug Class (Anti-inflammatory drugs, Bronchodilators, Combination therapy); Route of administration (Oral, Inhaled, Intravenous, Subcutaneous) and Geography

Report Code: TIPRE00004065 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Asthma is a chronic lung disease in which inflammation causes the bronchi to swell and narrow, resulting in breathing difficulties that can range from mild to life-threatening in considerable number of cases. The symptoms of asthma include, chest tightness, cough ,shortness of breath and wheezing. Asthma is caused by a number of environmental factors, including allergen exposure and air pollution. Asthma has been proven to have no cure, although it can be managed with early and effective asthma therapy. Anti-inflammatory drugs, corticosteroids, long-acting beta-agonists (LABA), and leukotriene modifiers are among the therapies used to treat asthma.


The "Global Asthma Therapeutics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the asthma therapeutics market with detailed market segmentation by product type, drug class, route of administration. The report provides key statistics on the market status of the leading asthma therapeutics market players and offers key trends and opportunities in the market.


  •   Based on product type the market is segmented as, dry powder inhalers, metered dose inhalers, mist inhalers and nebulizer.
  •   Based on drug class the market is segmented as, anti-inflammatory drugs, bronchodilators and combination therapy.
  •   Based on route of administration the market is segmented as, oral, inhaled, intravenous and subcutaneous.



  •   Increasing incidences of asthma and other respiratory disorders.
  •   Various risk factors such as, exposure to pollution, allergens, chemicals, practicing unhealthy lifestyles such as smoking are also expected to spur the market growth.
  •   Presence of robust pipeline of agents to manage asthma is also expected to spur market growth during the forecast period.


  •   However, patent expiration of drugs and high cost of asthma treatment are expected to restrain market growth during the forecast period.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The asthma therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the asthma therapeutics market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.


The report covers key developments in the asthma therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from asthma therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for asthma therapeutics in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the asthma therapeutics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  •   Koninklijke Philips N.V
  •   AstraZeneca
  •   GlaxoSmithKline Plc.
  •   Teva Pharmaceutical Industries Ltd.
  •   Boehringer Ingelheim International GmbH
  •   Sanofi
  •   Cipla Inc
  •   Intas Pharmaceuticals Ltd
  •   Merck Sharp and Dohme Corp
  •   F. Hoffmann-La Roche Ltd
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • The List of Companies

    - AstraZeneca
    - GlaxoSmithKline Plc.
    - Teva Pharmaceutical Industries Ltd.
    - Boehringer Ingelheim International GmbH
    - Sanofi
    - Cipla Inc
    - Intas Pharmaceuticals Ltd
    - Merck Sharp and Dohme Corp
    - F. Hoffmann-La Roche Ltd
    - Dr Reddy's Laboratories Ltd
    - Sunovion Pharmaceuticals, Inc
    - Abbott
    - Glenmark
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market


    Have a Question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

    Speak to Analyst
    • $3000 $2700
    • $4550 $4095
    • $6550 $5568
    • $8550 $6840

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount